Pfizer CEO Albert Bourla Says a Return to ‘normal’ Will Happen by End of 2022

Life for more than a year has been far from normal, or at least what “normal” was conceived to be before COVID-19 happened.

According to Pfizer CEO Albert Bourla, it will be a little while longer before the global world returns to normal. he told CNBC that he expects life could return to normal for developed countries by the end of this year and the rest of the world by the end of 2022.

By the end of next year, there should be enough Covid-19 vaccine doses for most world leaders to successfully inoculate their populations against the virus, said the CEO to Andrew Ross Sorkin at the CNBC Evolve Global Summit.

“I think the whole world will have enough volumes [of vaccine doses] by the end of 2022 to vaccinate, to protect everyone,” he said. “And I think that by the end of this year, the developed world will already be in this situation.”

Pfizer and German partner BioNTech reached the milestone of manufacturing 1 billion doses of their Covid vaccine earlier this month.

The two companies expect to produce up to 3 billion doses in 2021.

Pfizer and BioNTech have also previously pledged to provide 2 billion doses of the vaccine to low- and middle-income countries.

According to Bourla, Pfizer has contracts with more than 120 countries around the world. He said he expects more vaccines to go toward poorer countries in the second half of this year.

Disclaimer: We have no position in any of the companies mentioned and have not been compensated for this article.